94 related articles for article (PubMed ID: 23178165)
1. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status.
Gutiérrez-Rojas I; Lozano D; Nuche-Berenguer B; Moreno P; Acitores A; Ramos-Álvarez I; Rovira A; Novials A; Martín-Crespo E; Villanueva-Peñacarrillo ML; Esbrit P
Mol Cell Endocrinol; 2013 Jan; 365(2):309-15. PubMed ID: 23178165
[TBL] [Abstract][Full Text] [Related]
2. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.
Nuche-Berenguer B; Moreno P; Portal-Nuñez S; Dapía S; Esbrit P; Villanueva-Peñacarrillo ML
Regul Pept; 2010 Jan; 159(1-3):61-6. PubMed ID: 19586609
[TBL] [Abstract][Full Text] [Related]
3. Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.
Nuche-Berenguer B; Moreno P; Esbrit P; Dapía S; Caeiro JR; Cancelas J; Haro-Mora JJ; Villanueva-Peñacarrillo ML
Calcif Tissue Int; 2009 Jun; 84(6):453-61. PubMed ID: 19219381
[TBL] [Abstract][Full Text] [Related]
4. Amylin increases bone volume but cannot ameliorate diabetic osteopenia.
Romero DF; Bryer HP; Rucinski B; Isserow JA; Buchinsky FJ; Cvetkovic M; Liu CC; Epstein S
Calcif Tissue Int; 1995 Jan; 56(1):54-61. PubMed ID: 7796348
[TBL] [Abstract][Full Text] [Related]
5. Anabolic Effect of Insulin Therapy on the Bone: Osteoprotegerin and Osteocalcin Up-Regulation in Streptozotocin-Induced Diabetic Rats.
Bortolin RH; Freire Neto FP; Arcaro CA; Bezerra JF; da Silva FS; Ururahy MA; Souza KS; Lima VM; Luchessi AD; Lima FP; Lia Fook MV; da Silva BJ; Almeida MD; Abreu BJ; de Rezende LA; de Rezende AA
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):227-234. PubMed ID: 27651300
[TBL] [Abstract][Full Text] [Related]
6. Amylin and bone metabolism in streptozotocin-induced diabetic rats.
Horcajada-Molteni MN; Chanteranne B; Lebecque P; Davicco MJ; Coxam V; Young A; Barlet JP
J Bone Miner Res; 2001 May; 16(5):958-65. PubMed ID: 11341342
[TBL] [Abstract][Full Text] [Related]
7. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats.
Bortolin RH; da Graça Azevedo Abreu BJ; Abbott Galvão Ururahy M; Costa de Souza KS; Bezerra JF; Loureiro MB; da Silva FS; Marques DE; Batista AA; Oliveira G; Luchessi AD; Lima VM; Miranda CE; Lia Fook MV; Almeida Md; de Rezende LA; de Rezende AA
PLoS One; 2015; 10(5):e0125349. PubMed ID: 25933189
[TBL] [Abstract][Full Text] [Related]
8. Amylin effect in extrapancreatic tissues participating in glucose homeostasis, in normal, insulin-resistant and type 2 diabetic state.
Moreno P; Acitores A; Gutiérrez-Rojas I; Nuche-Berenguer B; El Assar M; Rodriguez-Mañas L; Gomis R; Valverde I; Visa M; Malaisse WJ; Novials A; González N; Villanueva-Peñacarrillo ML
Peptides; 2011 Oct; 32(10):2077-85. PubMed ID: 21939703
[TBL] [Abstract][Full Text] [Related]
9. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
11. Formononetin reverses established osteopenia in adult ovariectomized rats.
Tyagi AM; Srivastava K; Singh AK; Kumar A; Changkija B; Pandey R; Lahiri S; Nagar GK; Yadav DK; Maurya R; Trivedi R; Singh D
Menopause; 2012 Aug; 19(8):856-63. PubMed ID: 22781783
[TBL] [Abstract][Full Text] [Related]
12. Expression of RANKL/OPG during bone remodeling in vivo.
Tanaka H; Mine T; Ogasa H; Taguchi T; Liang CT
Biochem Biophys Res Commun; 2011 Aug; 411(4):690-4. PubMed ID: 21771583
[TBL] [Abstract][Full Text] [Related]
13. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia.
Nuche-Berenguer B; Lozano D; Gutiérrez-Rojas I; Moreno P; Mariñoso ML; Esbrit P; Villanueva-Peñacarrillo ML
J Endocrinol; 2011 May; 209(2):203-10. PubMed ID: 21372151
[TBL] [Abstract][Full Text] [Related]
15. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
[TBL] [Abstract][Full Text] [Related]
16. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
17. Influence of nano-hydroxyapatite coating implants on gene expression of osteogenic markers and micro-CT parameters. An in vivo study in diabetic rats.
de Oliveira PGFP; de Melo Soares MS; Silveira E Souza AMM; Taba M; Palioto DB; Messora MR; Ghiraldini B; Nunes FAS; de Souza SLS
J Biomed Mater Res A; 2021 May; 109(5):682-694. PubMed ID: 32608088
[TBL] [Abstract][Full Text] [Related]
18. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
[TBL] [Abstract][Full Text] [Related]
19. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
20. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro.
Ming LG; Lv X; Ma XN; Ge BF; Zhen P; Song P; Zhou J; Ma HP; Xian CJ; Chen KM
Endocrinology; 2013 Mar; 154(3):1202-14. PubMed ID: 23389955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
